EUVIMEDEUVIMED entdecken
Crossref

Clinical outcomes and health-system challenges in congenital afibrinogenemia: a single-centre prospective case series

Nita Radhakrishnan, Savitri Singh, Archit Pandharipande, Eby P Baby, Hari Gaire

Blood Cells, Molecules, and Diseases · 2026

DOI: 10.1016/j.bcmd.2026.102986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2026. Verfasst von Nita Radhakrishnan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, 201303, India. Electronic address: nitaradhakrishnan@yah…. Hauptthemen laut MEDLINE: Afibrinogenemia. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Congenital afibrinogenemia is a very rare bleeding disorder which is often life threatening. Data are scarce, and only 29 Indian cases have been officially reported to World Federation of Hemophilia, mostly as isolated descriptions. This study presents a prospectively followed pediatric cohort, evaluating clinical characteristics, outcomes with human fibrinogen concentrate (HFC), and health-system challenges. METHODS: Children diagnosed with afibrinogenemia between 2022 and 2025 at a tertiary centre were prospectively followed. Clinical presentation, diagnostic delay, prior treatments, and outcomes with HFC were analyzed, alongside a structured review of Indian literature and comparison with international data. RESULTS: Four children (ages 0.25-13 years) constituted 0.36% of the bleeding disorder cohort in our institutional registry (n = 1096). Median diagnostic delay was 8.2 years (range 0.25-12.5). Three were initially misdiagnosed as hemophilia. Major bleeds included recurrent hemarthroses, menorrhagia, and subgaleal/periorbital hematoma. All had Clauss fibrinogen

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AfibrinogenemiaHumansProspective StudiesChild, PreschoolFemaleAdolescentFibrinogenMaleChildInfantTreatment OutcomeHemorrhage

Substanzen

Fibrinogen

Autor:innen und Institutionen

  • Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, 201303, India. Electronic address: nitaradhakrishnan@yahoo.com.
  • Department of Pathology, Post Graduate Institute of Child Health, Noida, India. Electronic address: savipath8@gmail.com.
  • Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, 201303, India; Department of Medicine (Hematology), All India Institute of Medical Science, Nagpur, India. Electronic address:…
  • Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, 201303, India. Electronic address: ebypbaby5@gmail.com.
  • Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, 201303, India. Electronic address: megairehari1@gmail.com.

Zitieren

APA

Radhakrishnan, N., Singh, S., Pandharipande, A., Baby, E. P., & Gaire, H. (2026). Clinical outcomes and health-system challenges in congenital afibrinogenemia: a single-centre prospective case series. Blood Cells, Molecules, and Diseases. https://doi.org/10.1016/j.bcmd.2026.102986

Vancouver

Radhakrishnan N, Singh S, Pandharipande A, Baby EP, Gaire H. Clinical outcomes and health-system challenges in congenital afibrinogenemia: a single-centre prospective case series. Blood Cells, Molecules, and Diseases. 2026. doi:10.1016/j.bcmd.2026.102986

BibTeX
@article{Radhakrishnan2026,
  author = {Radhakrishnan, Nita and Singh, Savitri and Pandharipande, Archit and Baby, Eby P and Gaire, Hari},
  title = {Clinical outcomes and health-system challenges in congenital afibrinogenemia: a single-centre prospective case series},
  journal = {Blood Cells, Molecules, and Diseases},
  year = {2026},
  doi = {10.1016/j.bcmd.2026.102986}
}
Kostenlos starten →